Inhibitory Action of Natural Carrageenans on Herpes simplex Virus Infection of Mouse Astrocytes
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effects of the carrageenans 1T1 (λ-type), 1C1 (κ/ι-type) and 1C3 (ιι/ν-type), isolated from the red seaweed Gigartina skottsbergii, on herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infection of murine astrocytes were investigated. The three compounds were effective inhibitors of virus replication, as determined by a virus yield inhibition assay, in astrocytes as well as in Vero cells. The 50% inhibitory concentration was in the range of 0.9–3.6 and 0.4–3.2 μg/ml for astrocytes and Vero cells, respectively, whereas the 90% inhibitory concentration ranged from 6.5 to 17.0 μg/ml in astrocytes and from 3.5 to 22.2 μg/ml in Vero cells. No cytotoxicity was detected at concentrations of up to 1,000 μg/ml, indicating high selectivity indices for these compounds. Inhibition of viral cytopathology and antigen expression was also detected in the presence of the carrageenans. The increase in the expression of glial fibrillary acidic protein (GFAP), an activated astrocyte marker, produced during the course of HSV-1 infection in astrocytes, was reversed in the presence of 1C1 and 1C3. By contrast, the λ-carrageenan 1T1 increased the expression of GFAP, independently of HSV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis
Whitley, R. J., Alford, C. A., Hirsch, M. S., Schooley, R. T., Luby, J. P., Aoki, F. Y., Hanley, D., Nahmias, A. J., Soong, S.-J., & The NIAID Collaborative Antiviral Study Group* (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140303 · Cited by 896
Cited by
Carrageenans: Biological properties, chemical modifications and structural analysis – A review
Campo, V. L., Kawano, D. F., Silva, D. B. D., & Carvalho, I. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2009.01.020 · Cited by 1,403
Necas, J., & Bartosikova, L. (2013) · Veterinární medicína · doi:10.17221/6758-vetmed · Cited by 929
Medicinal and pharmaceutical uses of seaweed natural products: A review
Smit, A. J. (2004) · Journal of Applied Phycology · doi:10.1023/b:japh.0000047783.36600.ef · Cited by 806
“Carlucci et al. (1997, 1999a, 1999b) noted that λ-carrageenan and partially cyclized µ/ı́-carrageenan from Gigartina skottsbergii have potent antiviral effects against different strains of HSV types 1 and 2 during the virus adsorption stage.”
BackgroundIn the search of new functional food ingredients from algae
PLAZA, M., CIFUENTES, A., & IBANEZ, E. (2008) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2007.07.012 · Cited by 540
Innovative natural functional ingredients from microalgae
Plaza, M., Herrero, M., Cifuentes, A., & Ibáñez, E. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901070g · Cited by 509
Screening for bioactive compounds from algae
Plaza, M., Santoyo, S., Jaime, L., García-Blairsy Reina, G., Herrero, M., Señoráns, F. J., & Ibáñez, E. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.03.016 · Cited by 495
Seaweeds as a Functional Ingredient for a Healthy Diet
Peñalver, R., Lorenzo, J. M., Ros, G., Amarowicz, R., Pateiro, M., & Nieto, G. (2020) · Marine Drugs · doi:10.3390/md18060301 · Cited by 488
Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing
Yegappan, R., Selvaprithiviraj, V., Amirthalingam, S., & Jayakumar, R. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.06.086 · Cited by 462
Carrageenan: Drug Delivery Systems and Other Biomedical Applications
Pacheco-Quito, E.-M., Ruiz-Caro, R., & Veiga, M.-D. (2020) · Marine Drugs · doi:10.3390/md18110583 · Cited by 420
RETRACTED: Carrageenan: A natural seaweed polysaccharide and its applications
Prajapati, V. D., Maheriya, P. M., Jani, G. K., & Solanki, H. K. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.01.067 · Cited by 383
RetractedThe Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview
Wang, W., Wang, S.-X., & Guan, H.-S. (2012) · Marine Drugs · doi:10.3390/md10122795 · Cited by 381
Nutraceutical Potential of Seaweed Polysaccharides: Structure, Bioactivity, Safety, and Toxicity
Tanna, B., & Mishra, A. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12441 · Cited by 329
Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015388 · Cited by 253
Targeting heparin and heparan sulfate protein interactions
Weiss, R. J., Esko, J. D., & Tor, Y. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob01058c · Cited by 172
Gentscheva, G., Milkova-Tomova, I., Pehlivanov, I., Gugleva, V., Nikolova, K., Petkova, N., Andonova, V., Buhalova, D., & Pisanova, E. (2022) · Applied Sciences · doi:10.3390/app12199935 · Cited by 19
Metadata
- Authors
- Carlucci, M. J., Scolaro, L. A., & Damonte, E. B.
- Venue
- Chemotherapy
- Publisher
- S. Karger AG
- Published
- 1999
- Volume
- 45
- Issue
- 6
- Pages
- 429-436
- ISSN
- 0009-3157 (ISSN-L)
- 1421-9794
- OpenAlex
- W2082656455
- Cited by
- 103
- References
- 1
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.